The low frequencies of defective MMR in our cohorts were comparable with the reported rate of 1% to 3% in de novo head and neck squamous cell carcinoma.36 Interestingly, our data suggested higher protein expression of PD-1 and gene expression of CD4 in postradiation OCSCC than sporadic tumors. This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.